Home
Storia in 1 fonti
CMS adopts performance-based standards for CRC biomarker tests; evidence questions linger
CMS established a new national framework setting performance thresholds to qualify noninvasive, biomarker-based colorectal cancer screening options — including FDA-approved stool- and blood-based tests — for coverage.“The CMS coverage decision provides benchmarks for novel noninvasive tests to meet and exceed to gain coverage, and learn from the experience of currently approved
Raccontata da
healio.com
Timeline cronologica
- ·
ACG: New blood-based CRC test guidance asks ‘too much’ of patients navigating screening
ACG has issued a statement urging clinicians to interpret American Cancer Society’s revised colorectal cancer screening guidance with caution.In the statement, ACG expressed…
- ·
CMS adopts performance-based standards for CRC biomarker tests; evidence questions linger
CMS established a new national framework setting performance thresholds to qualify noninvasive, biomarker-based colorectal cancer screening options — including FDA-approved stool-…